MedPath

Music Therapy in Sickle Cell Pain Mixed Methods Study

Not Applicable
Completed
Conditions
Sickle Cell Disease
Interventions
Other: Music Listening
Other: Music Therapy
Registration Number
NCT02270060
Lead Sponsor
University Hospitals Cleveland Medical Center
Brief Summary

The purpose of this research study is to:

1. Investigate the effects of a single 20-minute music therapy intervention with a music therapist on the pain intensity, pain relief, and mood of adult patients with sickle cell disease as compared to:

1. Adult patients with SCD who listen to their preferred music for 20 minutes without the presence of a music therapist (music listening group)

2. Adult patients with SCD who receive standard care alone (control group)

2. Determine the feasibility (delivery, acceptability, and usefulness) of the music therapy intervention for pain management

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Subjects who have a diagnosis of sickle cell disease (HbSS, HbSC, HbSbeta+thal, or HbSbeta0thal)
  • 18 years or older
  • Able to speak and understand English
Exclusion Criteria
  • Patients who have significant hearing impairments and/or significant visual impairments that have not been corrected

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Music Listening GroupMusic ListeningPatient listens to his/her preferred music on an iPod touch for 20 minutes without the presence of a music therapist.
Music Therapy GroupMusic TherapyPatient receives a single 20-minute music therapy session with a music therapist. Patient will interact with specially composed music tailored to the patient's preferences using an iPad.
Primary Outcome Measures
NameTimeMethod
Change (Post - Pre) From Baseline in Visual Analog Scale of Pain Intensity (VASPI) of Memorial Pain Assessment CardBaseline and at end of 20-minute intervention, up to 120 minutes following randomization

Visual analog scale of pain intensity. The minimum score is 0. The maximum score is 10. Higher scores represent worse pain intensity.

Secondary Outcome Measures
NameTimeMethod
Change (Post- Pre) From Baseline in Visual Analog Scale of Mood (VASMOOD) of Memorial Pain Assessment CardBaseline and at end of 20-minute intervention, up to 120 minutes following randomization

Visual analog scale of mood. The minimum score is 0. The maximum score is 10. Higher scores represent better mood.

Length of Stay in MinutesFrom time of admission into acute care clinic to time of discharge, up to 8 hours.

Length of stay (in minutes) in acute care clinic

Change (Post - Pre) From Baseline in Tursky Scale of Memorial Pain Assessment CardBaseline and at end of 20-minute intervention, up to 120 minutes following randomization

Pain adjectives scale. The minimum score is 1. The maximum score is 7. Higher scores represent worse pain.

Change (Post - Pre) From Baseline in Numeric Pain Rating (NPR)From time of admission into acute care clinic to time of discharge, up to 8 hours.

Numeric pain rating between 0-10 before and after admission to acute care clinic. The minimum score is 0. The maximum score is 10. Higher scores represent worse pain.

Change (Post - Pre) From Baseline in Visual Analog Scale of Pain Relief (VASPR) of Memorial Pain Assessment CardBaseline and at end of 20-minute intervention, up to 120 minutes following randomization

Visual analog scale of Pain Relief. The minimum score is 0. The maximum score is 10. Higher scores represent greater pain relief.

Amount of HydromorphoneFrom time of admission into acute care clinic to time of discharge, up to 8 hours.

Amount of Hydromorphone received in acute care clinic following intervention

Trial Locations

Locations (1)

University Hospitals Seidman Cancer Center

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath